Ivermectin
WHY has the mainstream media been ignoring this information?
Why have social media platforms been censoring and removing this information?
Click on the country links below to see what doctors and people around the world are doing to address the COVID-19 pandemic.
Why have social media platforms been censoring and removing this information?
Click on the country links below to see what doctors and people around the world are doing to address the COVID-19 pandemic.
Ivermectin is helping to stem the tide of the SARS-COV-2 COVID-19 pandemic around the world. Scroll down to see what the mainstream media in the United States has failed to report.
INDIA:
This information is from mid August, 2020. Have you heard any of this on the "Nightly News?" Have you read it in a newspaper?
EXPERT RECOMMENDATION:
The Indian Journal of Pulmonology: https://www.thecompleteguidetohealth.com/ivermectinwhitepaper.html
GOVERNMENT PROTOCOLS:
| government_of_west_bengal_advisory_protocol_management_29_.09__2020.pdf |
| uttarakhand_covid-19_prophylaxis_ivermectin.pdf |
Please download, print out and share with others:
| covid-19_-_5_drugs_for_5_days.pdf |
AUSTRALIA:
New triple drug therapy protocol capable of preventing and curing COVID-19 is now available in Australia!
"We have a therapy that can fight COVID-19. The medications have been around for 50 years, they are cheap, FDA and Australian Therapeutic Goods Administration (TGA) approved and have an outstanding safety profile. Why are we just waiting around for a vaccine? To save lives we should be using whatever is safe and available right now. We could lead the world in this fight."
Professor Thomas Borody
MB, BS, BSc(Med), MD, PhD, DSc, FRACP, FACP, FACG, AGAF, FRS(N).
Professor Thomas Borody
MB, BS, BSc(Med), MD, PhD, DSc, FRACP, FACP, FACG, AGAF, FRS(N).
Professor Thomas Borody, famous for curing peptic ulcers using a triple antibiotic therapy saving millions of lives, has released the COVID-19 treatment protocol to general practitioners in Australia who can legally prescribe it to their COVID-19 positive patients, and can also prescribe it as a preventative medication.
Borody says this could be the fastest and safest way to end the pandemic in Australia within 6-8 weeks.
Borody says this could be the fastest and safest way to end the pandemic in Australia within 6-8 weeks.
Professor Borody says his research has led him to a triple therapy of Ivermectin, zinc and an antibiotic - which are all TGA and FDA approved. The therapy comprises:
- Ivermectin - TGA and FDA approved as an anti-parasitic therapy with an established safety profile since the 1970s. Known as the "Wonder Drug" from Japan.
- Zinc
- Doxycycline - TGA and FDA approved tetracycline antibiotic that fights bacterial infections, eg. acne or urinary tract infections, viral and malarial infections.
Listen to the audio interviews below...
"The three medications are on chemist shelves right now. General Practitioners can email GP@CDD.com.au to obtain the dosing protocol and COVID-19 treatment information for their patients."
"General Practitioners can legally prescribe the therapy today as an "off label" treatment according to Australian Guidelines - a standard practice in medicine. In fact, more than 60% of prescriptions in Australia are "off-label. It's not a new concept. It's happening every day to manage diseases and save lives."
"Australia has some of the best medical and science people in the world - indeed the Ivermectin connection was first discovered by Dr Kylie Wagstaff's team at Monash University in April. How long do we need to wait before Australian politicians get behind Australian medical science and use 'war room' tactics with safe and approved medications."
Professor Borody, an internationally regarded physician with 4 FDA approved drugs on the US and Australian markets, is famous for developing the triple therapy that cured peptic ulcers, saving more than 18,000 lives just in Australia and millions internationally.
"No trial has shown Ivermectin-based therapy to be INeffective. In-fact, international data reports an almost 100% cure rate and a symptom improvement within 4-6 days. We should share Australian findings from this triple therapy with the world," said Professor Borody.
"An Ivermectin tablet can cost as little as $2 - which could make it by far the cheapest, safest, and fastest cure for Australians and the Australian economy. This needs to be available for aged care facilities and frontline health workers today."
"We have written the Federal Health Minister Greg Hunt and Victorian Premier Daniel Andrews for an urgent medical briefing to bypass the raft of 'advisors' who need to know TGA-approved medicines do not require animal studies and prolonged clinical trials already done to approve them in the first place."
"The Government could end the pandemic by openly encouraging General Practitioners to prescribe these TGA approved medications. Those who test positive, are identified in contact tracing, as well as those in high-risk groups like the elderly and healthcare workers, can then access the therapy quickly," said Professor Borody.
Results have been very promising.
At Broward County Medical Centre in Florida, mortality in already sick patients dropped by 48 per cent. Last week the most populous Indian state, Uttar Pradesh, approved the use of Ivermectin for COVID-19 patients and also as a preventative treatment for health workers.
In Bangladesh, 400 patients with mild to moderate symptoms were treated and 98 per cent cleared the virus within four to 14 days.
In the Dominican Republic, in 1300 patients the average duration of infection fell from 21 days to 10 days.
Clinical trials on his Ivermectin triple therapy are underway in 32 countries and are about to start in California.
Dr. Borody says the trick is “treating patients very early”, within seven days of onset, before the virus spreads through their organs and makes them sick. “If nothing else, make it available in aged care homes immediately. Our elderly are at the highest risk and this is a very safe option, especially when we have nothing else except ventilators.”
Dr. Borody has joined forces with California researcher Dr. Sabine Hazan, founder of Ventura Clinical Trials, to fund trials themselves, at around $3500 per patient.
If the trials go well, with expedited FDA approval, the Ivermectin triple therapy could be on the market in blister packs before Christmas. That’s for patients in America. Australia will have to wait.
Ivermectin was discovered in the 1970s and is on the World Health Organization (WHO) list of essential medicines.
"There is mounting worldwide clinical literature pointing to a 100% cure rate using Ivermectin Triple Therapy," he said.
Professor Thomas Borody MB, BS, BSc(Med), MD, PhD, DSc, FRACP, FACP, FACG, AGAF, FRS(N):
https://centrefordigestivediseases.com/about-us/professor-thomas-borody/
General Practitioners can email GP@CDD.com.au to obtain the dosing protocol and COVID-19 treatment information for their patients.
For interviews with Thomas Borody, please contact:
Kate Newton, Digital Mantra Group
Email: team@DMGPR.com
AU: +61 2 8218 2144
US: +1 415 951 3228
ASIA: +65 3159 3427
https://centrefordigestivediseases.com/about-us/professor-thomas-borody/
General Practitioners can email GP@CDD.com.au to obtain the dosing protocol and COVID-19 treatment information for their patients.
For interviews with Thomas Borody, please contact:
Kate Newton, Digital Mantra Group
Email: team@DMGPR.com
AU: +61 2 8218 2144
US: +1 415 951 3228
ASIA: +65 3159 3427
THE OFFICIAL AUSTRALIAN RECOMMENDATIONS
THE FLORIDA KEYS:
Kyle Carter Testimonial - MUST WATCH !
Dr. Bruce Boros, a cardiologist who owns and operates all three of the Keys’ Advanced Urgent Care clinics, was one of the earliest healthcare professionals along the island chain to sound the alarm about the dangers of the novel coronavirus, urging social distancing and mask-wearing.
One of his patients was Kyle Carter, a 45-year-old music promoter living in Key West. Carter is a big man. He stands six feet, four inches and weighs around 290. He’s had several surgeries in his life, but is otherwise healthy. On July 3, he was helping a friend empty out a trailer in the summer heat. He felt a little weak, but he didn’t think too much about it.
“The sun in Key West is enough to do it to you,” he said. “COVID crossed my mind, but I didn’t think it was a big deal.”
For about three days, he felt like he had the flu. By Day 5, he had a fever of more than 103 degrees, “and I’m really feeling pretty awful,” Carter said. Five days later, he had a bad cough and trouble breathing. On the 11th day of the illness, Dr. Boros’ staff X-rayed his lungs and the right one was filled with fluid. He tested positive for COVID-19 and had developed viral pneumonia.
Boros told him about ivermectin, which he had been reading about as a possible treatment for COVID, and asked him if he wanted to try it. He did.
“By that point, I would try anything,” Carter said.
Boros said that Carter was on the verge of having to go on a ventilator, which he said is when most deaths occur.
“He was really sick,” Boros said. “He was going down the tubes fast and was going to wind up on a ventilator.”
Starting around 4 p.m. that day, Carter took nine pills (3mg each) at first, five more about two hours later, and the four more early the next morning.
“Within 12 hours, I was starting to feel better. Twenty-four hours later, I’m out of the hospital and my actual symptoms have gone away,” he said. “I could speak entire sentences without having to cough.”
Other than a slight malaise, Carter said last week he is symptom free.
Boros believes in ivermectin’s effectiveness so much that he gives it to all his patients showing signs of COVID-19, especially since the drug has few known negative side effects.
“It’s really the answer,” he said.
And, more importantly, the sooner patients start treatment, the better the outcome, he said.
https://www.miamiherald.com/news/local/community/florida-keys/article245313450.html
BROWARD COUNTY FLORIDA:
Jean-Jacques Rajter, MD
1001 S. Andrews Ave
Suite 100
Fort Lauderdale, FL 33316
954-906-6000
COVID19@PSCFlorida.com
To the best of our knowledge, we believe that Dr. Jean-Jacques Rajter may have been the very first doctor in the WORLD to save a patient's life by utilizing ivermectin as part of his COVID-19 protocol.
In April 2020, Dr. Jean-Jacques Rajter, a Fort Lauderdale pulmonologist with the Broward Health system, began prescribing ivermectin and his reported patients’ outcomes led the hospital system to approve it as a COVID-19 treatment.
Early that month, one of his patients in the hospital was very ill with COVID-19. She required 50 percent oxygen to breathe. The woman’s son was persistent that more could be done for his mother before she would have to go on a ventilator.
Rajter’s wife, Dr. Juliana Cepelowicz-Rajter, also a pulmonologist, had read a recent study out of Australia where high doses of ivermectin killed COVID cells in the lab. The woman’s son read about the same study and asked Rajter if his mother could be treated with the drug.
But Rajter said the levels used in the study could be toxic if given to a person. The son then asked about the approved dose for humans, which is 200 micrograms per kilogram of weight.
The woman agreed to the treatment, and the results were almost immediate. Within 48 hours, she showed significant improvement. Rajter was so encouraged that he successfully treated two more critically ill patients with ivermectin that month.
And, at around $7 a pill, it’s an inexpensive protocol.
Rajter co-authored a retrospective study in June that he has submitted to scientific journals for publication that assessed 280 adult COVID-19 patients. One-hundred-seventy-three of the participants were given ivermectin and 107 were treated with standard care.
More importantly, he said, was that of the high-risk patients participating in the study, who were suffering from severe pulmonary disease, 81 percent of those not receiving ivermectin died, compared with 39 percent of those taking the drug.
The overall mortality rate of those given the drug was 15 percent, compared to 25 percent of the other sample group, Rajter said.
To the best of our knowledge, we believe that Dr. Jean-Jacques Rajter may have been the very first doctor in the WORLD to save a patient's life by utilizing ivermectin as part of his COVID-19 protocol.
In April 2020, Dr. Jean-Jacques Rajter, a Fort Lauderdale pulmonologist with the Broward Health system, began prescribing ivermectin and his reported patients’ outcomes led the hospital system to approve it as a COVID-19 treatment.
Early that month, one of his patients in the hospital was very ill with COVID-19. She required 50 percent oxygen to breathe. The woman’s son was persistent that more could be done for his mother before she would have to go on a ventilator.
Rajter’s wife, Dr. Juliana Cepelowicz-Rajter, also a pulmonologist, had read a recent study out of Australia where high doses of ivermectin killed COVID cells in the lab. The woman’s son read about the same study and asked Rajter if his mother could be treated with the drug.
But Rajter said the levels used in the study could be toxic if given to a person. The son then asked about the approved dose for humans, which is 200 micrograms per kilogram of weight.
The woman agreed to the treatment, and the results were almost immediate. Within 48 hours, she showed significant improvement. Rajter was so encouraged that he successfully treated two more critically ill patients with ivermectin that month.
And, at around $7 a pill, it’s an inexpensive protocol.
Rajter co-authored a retrospective study in June that he has submitted to scientific journals for publication that assessed 280 adult COVID-19 patients. One-hundred-seventy-three of the participants were given ivermectin and 107 were treated with standard care.
More importantly, he said, was that of the high-risk patients participating in the study, who were suffering from severe pulmonary disease, 81 percent of those not receiving ivermectin died, compared with 39 percent of those taking the drug.
The overall mortality rate of those given the drug was 15 percent, compared to 25 percent of the other sample group, Rajter said.
ICON (Ivermectin in COvid Nineteen) Study: Use of Ivermectin Is Associated with Lower Mortality in Hospitalized Patients with COVID-19
Methodology:
Patients in the Ivermectin group received at least one oral dose of Ivermectin at 200 micrograms/kilogram in addition to usual clinical care. The decision to prescribe Ivermectin, hydroxychloroquine, azithromycin or other medications was at the discretion of the treating physicians, however hospital guidelines were established for the use of these agents as well as for cardiac and QT monitoring for patients receiving hydroxychloroquine. Oxygen and ventilatory support were applied per the customary care.
Results:
The primary outcome was a statistically significant reduction in all-cause in-hospital mortality. Patients were considered a “survivor” if they left the hospital alive, or if their status in the hospital changed from active care to awaiting transfer to a skilled facility. The latter outcome was necessitated by the requirement that two consecutive negative nasopharyngeal swab specimens for SARS- CoV-2, collected equal to or greater than 24 hours apart, were necessary for a patient to be accepted to a skilled nursing facility.
Conclusion:
Overall mortality was significantly lower in the Ivermectin group than in the usual care group (15.0% vs 25.2%, for Ivermectin and usual care respectively, p=.03). Mortality was also lower for Ivermectin treated patients in the subgroup of patients with severe disease (38.8% vs. 80.7%, p=.001).
Key Findings:
● Ivermectin administration was associated with statistically significant lower mortality among patients with COVID-19, particularly in patients with more severe disease.
● The Cox regression showed Ivermectin was associated with a significantly lower hazard ratio for mortality of 0.37 (CI 0.19 - 0.70, p=.003).
ARTICLES:
ORLANDO, FLORIDA:
WEST MONROE, LOUISIANA:
PHILADELPHIA, PENNSYLVANIA
Outpatient Use of Ivermectin in COVID-19
https://clinicaltrials.gov/ct2/show/NCT04530474
Temple University Hospital
Philadelphia, Pennsylvania, United States, 19140
Contact: Derek Isenberg, MD 215-707-8020 derek.isenberg@tuhs.temple.edu
Contact: Nina Gentile, MD 215-707-8020 nina.gentile@tuhs.temple.edu
Please refer to this study by its ClinicalTrials.gov identifier:
NCT number: NCT04530474
UNFORTUNATELY, this trial appears to be designed to FAIL:
FAILS to provide an adequate dose of Ivermectin.
FAILS to include doxycycline.
FAILS to include zinc.
FAILS to be in very much of a hurry:
Estimated Study Start Date: October 1, 2020
Estimated Primary Completion Date: June 30, 2021
Estimated Study Completion Date: December 31, 2021
https://clinicaltrials.gov/ct2/show/NCT04530474
Temple University Hospital
Philadelphia, Pennsylvania, United States, 19140
Contact: Derek Isenberg, MD 215-707-8020 derek.isenberg@tuhs.temple.edu
Contact: Nina Gentile, MD 215-707-8020 nina.gentile@tuhs.temple.edu
Please refer to this study by its ClinicalTrials.gov identifier:
NCT number: NCT04530474
UNFORTUNATELY, this trial appears to be designed to FAIL:
FAILS to provide an adequate dose of Ivermectin.
FAILS to include doxycycline.
FAILS to include zinc.
FAILS to be in very much of a hurry:
Estimated Study Start Date: October 1, 2020
Estimated Primary Completion Date: June 30, 2021
Estimated Study Completion Date: December 31, 2021
ARGENTINA:
Ivermectin treatments started
Nine Argentine health centers began to administer ivermectin due to the acceleration of the recovery of those infected.
http://supercampo.perfil.com/2020/07/coronavirus-hospitales-argentinos-usan-ivermectina-tratamientos-enfermos/
Nine Argentine health centers began to administer ivermectin due to the acceleration of the recovery of those infected.
http://supercampo.perfil.com/2020/07/coronavirus-hospitales-argentinos-usan-ivermectina-tratamientos-enfermos/
RESULTS POSITIVE OF THE PROTOCOL IVER.CAR IN THE PROPHYLAXIS OF THE AGENTS OF HEALTH
http://www.pharmabaires.com/1739-resultados-positivos-del-protocolo-iver-car-en-la-profilaxis-de-los-agentes-de-salud.html
http://www.pharmabaires.com/1739-resultados-positivos-del-protocolo-iver-car-en-la-profilaxis-de-los-agentes-de-salud.html
Study reveals that ivermectin reduces viral load in patients infected with SARS-CoV-2
https://www.conicet.gov.ar/estudio-revela-que-la-ivermectina-reduce-la-carga-viral-en-pacientes-infectados-con-sars-cov-2/
https://www.conicet.gov.ar/estudio-revela-que-la-ivermectina-reduce-la-carga-viral-en-pacientes-infectados-con-sars-cov-2/
A study demonstrates the antiviral response of ivermectin in patients with COVID-19
Wednesday, September 23, 2020
This is a clinical trial, funded by the R + D + ia Agency through the Call for Ideas-COVID-19 Project, which demonstrates the drug's ability to combat the virus in the early stages of infection.
Recruitment was completed and the results of the project "Evaluation of the antiviral effect of the drug ivermectin against SARS-CoV-2", carried out by a public-private consortium led by Dr. Alejandro Krolewiecki from the Institute of Tropical Diseases Research from the Oran Regional Headquarters of the National University of Salta (UNSa), which received funding from the R & D & I Agency within the framework of the Call for Ideas-COVID-19 Project of the “Coronavirus Unit” for an amount of $ 6,000 .000 pesos.
The study evaluating the effect of ivermectin on the replication of SARS-CoV-2 in patients with COVID-19 found that the administration of ivermectin at a dose of 0.6 milligrams per kilogram of weight (three times the usual amount) produces the faster and deeper shedding of the virus when treatment is started early in the infection (up to 5 days from the onset of symptoms).
The finding of the antiviral activity of ivermectin is the result of a clinical study on 45 patients with mild or moderate disease in different hospital centers (CEMIC, Muñiz and Alta Cuenca de Cañuelas), among which 30 patients were administered ivermectin in high doses The rest were not, and drug safety measurements, virus quantification in respiratory secretions and ivermectin levels in blood were made. Patients who received ivermectin presented a significantly different antiviral response than those not treated, the effect was evidenced in the deeper decrease of virus secretions.
Currently the project has approvals from the ANMAT and in the future it must define the best way to determine if the identified effect translates into a clinical and / or epidemiological utility and, in this case, the mode of administration with the necessary safety and efficacy measures.
High doses of Ivermectin, why?
The ivermectin assay has a background in an article published in "Antiviral Research" by Caly et al., Australian researchers showing the inhibition of SARS-CoV-2 in Vero cells in-vitro . In other words, "the study is limited to looking at the effects in test tubes," according to Krolewiecki.
Ivermectin is an antiparasitic drug widely used in human and veterinary medicine, and according to the CONICET researcher at the National University of Salta, “the limitations of the in-vitro model are that it ignores the immune component of the host and does not take into account the balance between drug concentration versus viral load ” , something that is typical in the evaluation of the antiviral activity of drugs in Acute Respiratory Infections such as COVID-19 and influenza.
The design, development and analysis of the study is a public-private cooperation formed by the Veterinary Research Center of Tandil (CIVETAN), UNCPBA-CICPBA-CONICET; the Biotechnological Services Platform-COMTra-National University of Quilmes; the EleaPhoenix SA Laboratory (co-financed the project); the Tropical Diseases Research Institute - National University of Salta - CONICET and the Virology Laboratory of the Garrahan Hospital.
About the "Coronavirus Unit"
Its objective is to make available all the capacities for the development of technological projects, human resources, infrastructure and equipment that may be required to carry out diagnostic and research tasks on the SARS-CoV-2 Coronavirus.
The study evaluating the effect of ivermectin on the replication of SARS-CoV-2 in patients with COVID-19 found that the administration of ivermectin at a dose of 0.6 milligrams per kilogram of weight (three times the usual amount) produces the faster and deeper shedding of the virus when treatment is started early in the infection (up to 5 days from the onset of symptoms).
The finding of the antiviral activity of ivermectin is the result of a clinical study on 45 patients with mild or moderate disease in different hospital centers (CEMIC, Muñiz and Alta Cuenca de Cañuelas), among which 30 patients were administered ivermectin in high doses The rest were not, and drug safety measurements, virus quantification in respiratory secretions and ivermectin levels in blood were made. Patients who received ivermectin presented a significantly different antiviral response than those not treated, the effect was evidenced in the deeper decrease of virus secretions.
Currently the project has approvals from the ANMAT and in the future it must define the best way to determine if the identified effect translates into a clinical and / or epidemiological utility and, in this case, the mode of administration with the necessary safety and efficacy measures.
High doses of Ivermectin, why?
The ivermectin assay has a background in an article published in "Antiviral Research" by Caly et al., Australian researchers showing the inhibition of SARS-CoV-2 in Vero cells in-vitro . In other words, "the study is limited to looking at the effects in test tubes," according to Krolewiecki.
Ivermectin is an antiparasitic drug widely used in human and veterinary medicine, and according to the CONICET researcher at the National University of Salta, “the limitations of the in-vitro model are that it ignores the immune component of the host and does not take into account the balance between drug concentration versus viral load ” , something that is typical in the evaluation of the antiviral activity of drugs in Acute Respiratory Infections such as COVID-19 and influenza.
The design, development and analysis of the study is a public-private cooperation formed by the Veterinary Research Center of Tandil (CIVETAN), UNCPBA-CICPBA-CONICET; the Biotechnological Services Platform-COMTra-National University of Quilmes; the EleaPhoenix SA Laboratory (co-financed the project); the Tropical Diseases Research Institute - National University of Salta - CONICET and the Virology Laboratory of the Garrahan Hospital.
About the "Coronavirus Unit"
Its objective is to make available all the capacities for the development of technological projects, human resources, infrastructure and equipment that may be required to carry out diagnostic and research tasks on the SARS-CoV-2 Coronavirus.
Alternative to the choice of health and sick personnel
In Salta, ivermectin is already prescribed to prevent COVID
This was confirmed by the Minister of Health, Juan José Esteban, stating that first, workers from the Hospital del Milagro began to take it and now it is prescribed to patients with underlying diseases and the elderly.
https://www.pagina12.com.ar/294612-en-salta-ya-se-prescribe-la-ivermectina-para-prevenir-la-cov
In Salta, ivermectin is already prescribed to prevent COVID
This was confirmed by the Minister of Health, Juan José Esteban, stating that first, workers from the Hospital del Milagro began to take it and now it is prescribed to patients with underlying diseases and the elderly.
https://www.pagina12.com.ar/294612-en-salta-ya-se-prescribe-la-ivermectina-para-prevenir-la-cov
BRAZIL:
Click below to read the article...
THE ABOVE VIDEO WAS CENSORED BY YOUTUBE
Ministry of Health plans “D-Day” against Covid-19: “Early treatment is life”
https://gazetabrasil.com.br/especiais/coronavirus/covidao/ministerio-da-saude-planeja-dia-d-contra-covid-19-tratamento-precoce-e-vida/
An excerpt from the above article:
Secretaria de Saúde de Natal recomenda usar ivermectina para prevenir e tratar coronavírus; SAIBA COMO.
https://agorarn.com.br/geral/secretaria-de-saude-de-natal-recomenda-usar-ivermectina-para-prevenir-e-tratar-coronavirus-saiba-como/
https://agorarn.com.br/geral/secretaria-de-saude-de-natal-recomenda-usar-ivermectina-para-prevenir-e-tratar-coronavirus-saiba-como/
The Brazilian city being turned into a coronavirus “lab experiment”
https://www.codastory.com/waronscience/brazil-covid19-ivermectin/
PERU:
Peru is one very few countries that has allowed Ivermectin to be added to the national clinical therapy list in association with COVID-19.
Peru approves Ivermectin for COVID-19:Modify the Technical Document: Prevention, Diagnosis and Treatment of people affected by COVID-19 in Peru ministerial resolution N 270-2020-MINSA.
https://busquedas.elperuano.pe/normaslegales/modifican-el-documento-tecnico-prevencion-diagnostico-y-tr-resolucion-ministerial-n-270-2020-minsa-1866159-4/
https://busquedas.elperuano.pe/normaslegales/modifican-el-documento-tecnico-prevencion-diagnostico-y-tr-resolucion-ministerial-n-270-2020-minsa-1866159-4/
Peru has accepted Ivermectin as a COVID-19 treatment, however the government’s decision was not based on formal, randomized controlled trials. Instead, a network of many doctors in and around Peru drove a kind of community movement to use the medicine to treat COVID-19.
Doctors started using Ivermectin and reporting positive results to colleagues. The government came to the conclusion that a sufficient number of experts in the country had formed a consensus that could not be ignored. Thus, Ivermectin is being used on a wide scale in Peru, in combination with other drugs like hydroxychloroquine, azithromycin and chloroquine phosphate. Dosage protocols for the treatment of mild, moderate and severe forms of COVID-19, using the above combinations, have been established.
Doctors started using Ivermectin and reporting positive results to colleagues. The government came to the conclusion that a sufficient number of experts in the country had formed a consensus that could not be ignored. Thus, Ivermectin is being used on a wide scale in Peru, in combination with other drugs like hydroxychloroquine, azithromycin and chloroquine phosphate. Dosage protocols for the treatment of mild, moderate and severe forms of COVID-19, using the above combinations, have been established.
Real World Evidence (RWE) The Case of Peru
https://www.researchgate.net/publication/344294031_Real_World_Evidence_RWE_El_Caso_de_Peru
BANGLADESH:
Following the Monash-Doherty research, physicians at a Dhaka hospital have observed cumulative efficacy of a combination therapy of Ivermectin and doxycycline in Covid-19 patients. The medication was tested in 60 patients. After 72 hours of drug administration, the majority of the patients’ conditions started improving. The average recovery time was noted to be 11 days. Out of 60 COVID-19 patients, all recovered as the combination of the two drugs were applied.
https://www.thedailystar.net/frontpage/news/use-ivermectin-hope-held-out-caution-called-1914041
Bangladesh Study Suggests that Ivermectin Combo can Treat COVID-19
https://www.trialsitenews.com/bangladesh-study-suggests-that-ivermectin-combo-can-treat-covid-19/
A Case Series of 100 COVID-19 Positive Patients Treated with Combination of Ivermectin and Doxycycline
https://www.banglajol.info/index.php/JBCPS/article/view/47512
Comparison of Viral Clearance between Ivermectin with Doxycycline and Hydroxychloroquine with Azithromycin in COVID-19 Patients
https://www.banglajol.info/index.php/JBCPS/article/view/47514
https://www.trialsitenews.com/bangladesh-study-suggests-that-ivermectin-combo-can-treat-covid-19/
A Case Series of 100 COVID-19 Positive Patients Treated with Combination of Ivermectin and Doxycycline
https://www.banglajol.info/index.php/JBCPS/article/view/47512
Comparison of Viral Clearance between Ivermectin with Doxycycline and Hydroxychloroquine with Azithromycin in COVID-19 Patients
https://www.banglajol.info/index.php/JBCPS/article/view/47514
BOLIVIA:
The clinical files of Ivermectin against Covid-19
https://elpais.bo/reportajes/20200920_los-expedientes-clinicos-de-la-ivermectina-contra-el-covid-19.html
The Minister of Health, Marcelo Navajas, reported on May 12, 2020 that ivermectin was included, through Resolution No. 259, in the 'National List of Essential Medicines 2018-2020', and that it may be used for the treatment of patients with coronavirus (COVID-19), under medical protocol and informed consent.
Ministry of Health authorizes use of ivermectin against COVID-19 under protocol
https://www.minsalud.gob.bo/4157-ministerio-de-salud-autoriza-uso-de-ivermectina-contra-el-covid-19-bajo-protocolo
https://www.minsalud.gob.bo/4157-ministerio-de-salud-autoriza-uso-de-ivermectina-contra-el-covid-19-bajo-protocolo
Trinidad, a city in Bolivia, initiated a campaign to combat COVID-19 by distributing free doses of Ivermectin in an effort to take on the pathogen in the eastern region of the country where more have contracted the virus.
HONDURAS:
Catracho – as Hondurans are colloquially called – is an acrostic made up of the names (in English) of its main components: colchicine, anti-inflammatories, tocilizumab, ivermectin, blood thinners, and hydroxychloroquine.
The Central American country had one of the highest fatality rates from coronavirus in Latin America. On March 10th, the first case of covid-19 was reported in Honduras and at the beginning of April the mortality rate was 14.5%. On April 23, a multi-mechanism treatment protocol based on the pathophysiology of covid-19 was implemented and by July 18TH, 31,966 patients were confirmed with the disease. The fatality rate at that time had decreased to 2.66%, representing a decrease of 81.6%.
"I am proud that we can tell the world that Honduras has become part of contemporary world history with golden letters, that is something that no one will take from us" the Honduran Doctor Miguel Sierra-Hoffman said, in reference to the contribution of Honduras to science and finding a cure against the novel coronavirus. Doctor Sierra exercise medicine in the United States of America.
"We have given the world an answer on how to address the virus in critically ill patients, lowering mortality in Honduras, a country with many limitations and with one of the worst prognoses when the pandemic entered," said the doctor. According to Sierra-Hoffman, "from a scientific point of view it is a great merit and achievement for humanity".
The president of Honduras, Juan Orlando Hernández, congratulated the team of researchers. "We have to be proud of what is ours in the midst of this tragedy and Catracho is an example of this since it has been structured by Honduran doctors such as Dr. Sierra Hoffman, a Honduran who lives in Houston and has a very important position in the world of health and medicine. And also, the doctors Fernando Valerio, Óscar Díaz and Videa, whose guidance has been essential to carry out the economic reopening of our country" President Hernández said.
For more information: https://covid19honduras.org/
The Central American country had one of the highest fatality rates from coronavirus in Latin America. On March 10th, the first case of covid-19 was reported in Honduras and at the beginning of April the mortality rate was 14.5%. On April 23, a multi-mechanism treatment protocol based on the pathophysiology of covid-19 was implemented and by July 18TH, 31,966 patients were confirmed with the disease. The fatality rate at that time had decreased to 2.66%, representing a decrease of 81.6%.
"I am proud that we can tell the world that Honduras has become part of contemporary world history with golden letters, that is something that no one will take from us" the Honduran Doctor Miguel Sierra-Hoffman said, in reference to the contribution of Honduras to science and finding a cure against the novel coronavirus. Doctor Sierra exercise medicine in the United States of America.
"We have given the world an answer on how to address the virus in critically ill patients, lowering mortality in Honduras, a country with many limitations and with one of the worst prognoses when the pandemic entered," said the doctor. According to Sierra-Hoffman, "from a scientific point of view it is a great merit and achievement for humanity".
The president of Honduras, Juan Orlando Hernández, congratulated the team of researchers. "We have to be proud of what is ours in the midst of this tragedy and Catracho is an example of this since it has been structured by Honduran doctors such as Dr. Sierra Hoffman, a Honduran who lives in Houston and has a very important position in the world of health and medicine. And also, the doctors Fernando Valerio, Óscar Díaz and Videa, whose guidance has been essential to carry out the economic reopening of our country" President Hernández said.
For more information: https://covid19honduras.org/
Honduras treatment for COVID-19 stands out worldwide
https://www.prnewswire.com/news-releases/honduras-treatment-for-covid-19-stands-out-worldwide-301139390.html
https://www.prnewswire.com/news-releases/honduras-treatment-for-covid-19-stands-out-worldwide-301139390.html
EL SALVADOR
El Salvador has included Ivermectin in their protocols.
DOMINICAN REPUBLIC:
Doctors cure 6,000 patients with Covid-19 with Ivermectin
https://dominicantoday.com/dr/covid-19/2020/09/29/doctors-cure-6000-patients-with-covid-19-with-ivermectin/
https://dominicantoday.com/dr/covid-19/2020/09/29/doctors-cure-6000-patients-with-covid-19-with-ivermectin/
CLICK ABOVE TO READ ARTICLE
President of One of Largest Dominican Republic Private Health Systems: Ivermectin has Helped Treat 6,000 Patients
https://www.trialsitenews.com/president-of-one-of-largest-dominican-republic-private-health-systems-ivermectin-has-helped-treat-6000-patients/
https://www.trialsitenews.com/president-of-one-of-largest-dominican-republic-private-health-systems-ivermectin-has-helped-treat-6000-patients/
President of Dominican Republic’s Largest Private Health Group Discusses the Success of Ivermectin as a Treatment for Early Stage COVID-19
https://www.trialsitenews.com/president-of-dominican-republics-largest-private-health-group-discusses-the-success-of-ivermectin-as-a-treatment-for-early-stage-covid-19/
https://centromedicopuntacana.com/
Contact the Dominican Republic Rescue Group: Physicians and investigators interested in learning more can contact Dr. Jose Natalio Redondo directly at his email address: josenatalioredondo@gmail.com
https://www.trialsitenews.com/president-of-dominican-republics-largest-private-health-group-discusses-the-success-of-ivermectin-as-a-treatment-for-early-stage-covid-19/
https://centromedicopuntacana.com/
Contact the Dominican Republic Rescue Group: Physicians and investigators interested in learning more can contact Dr. Jose Natalio Redondo directly at his email address: josenatalioredondo@gmail.com
Puerto Plata:
Centro Médico Bournigal
Calle Antera Mota esq. Dr. Zafra
Tel 809 586-2342
Punta Cana:
Centro Médico Punta Cana
Avenida España No. 1, Bávaro La Altagracia
Télefono: 809 552-1506
Centro Médico Bournigal
Calle Antera Mota esq. Dr. Zafra
Tel 809 586-2342
Punta Cana:
Centro Médico Punta Cana
Avenida España No. 1, Bávaro La Altagracia
Télefono: 809 552-1506
COSTA RICA:
Ivermectina is available over the counter without a prescription in Costa Rica.
PANAMA:
GUATEMALA:
This is the bag of medicines and nutritional supplements that are used in the COVID-19 protocol, for patients with mild symptoms in the Republic of Guatemala, and IVERMECTIN is the one that goes first as treatment.
PHILIPPINES
| dosaging_of_ivermectin.pdf |
| ivermectins_6_mechanisms_of_action.pdf |
| covid_19_treatment_protocol.pdf |
"I am Dr. Allan A. Landrito and I have been a practicing Integrative Medical Doctor since 2005. Right now I am connected with the City Health Department of Muntinlupa, and serving in my capacity as a front-liner in this institution.
I have sucessful experiences in handling COIVID-19 patients giving intravenous Vitamin C and DMSO. I always give Ivermectin 15mg to adult patients and I am seeing that symptomatic swab-positive patients are responding to this. It takes usually 3-4 days then I am surprised that patients are improving.
For example, there is this 57-year old male patient, diabetic and hypertensive, who is manifesting COVID-19 symptoms for 2 weeks and seen by other physicians, and given Cefuroxime, then Azithromycin, then asked my help while the condition has already progressed that the patient having much difficulty of breathing. The family even bought an oxygen tank because hospitals would not want to admit him having reached full capacity in the government hospitals they went to. I gave Ivermectin capsule 15mg. We were arranging for a nurse who can attend to him while I was preparing the iv Vitamin C. on the 4th day while the nurse was ready to go to the patient to give the iv Vitamin C, the patient surprisingly cancelled the Vitamin C simply because he had improved already.
I had another experience. This time about Vitamin C. The patient is a 68 year old female who had penumonia on x-ray presenting with fever, cough, weakness with a background of diabetes. Five days before this consultation her 68 year old husband died from COVID-19. The husband has no co-morbidities - not obese, not diabetic, not hypertensive, who presented with 5 day headache and fever, then suddenly died. Swab test showed positive result. And so when I saw this patient I gave her Ivermectin 15 mg, then I immedaitely gave her intravenous Vitamin C 50 gm. Two days later, the patient is still weak. So I gave another 50 gm intravenous Vitamin C plus 10 ml DMSO. Then the patient improved. I saw her after a week and she has regained back her health. Of course, she is depressed because she is still grieving form the loss of her husband. The whole family took Ivermectin, 15 mg each as prophylaxis, and they did not manifest the disease except for her son-in-law who presented with diarrhea. In a matter of 3 days the son-in-law was also well.
I had another patient who is a 33-year old female who has been suffering for one month from cough, fever, vomiting, diarrhea, shooting pain on chest, back and nape. I gave intravenous Vitamin C 25 gms. I gave Ivermectin 15 mg but she vomited this out. I have not seen the patient thereafter. She is a young patient, strong, but is a long hauler. Today, after 3 weeks, I received a surprise call form her informing and thanking me that she is already COVID-19 - free but still with slight symptoms.
I am sharing these experiences and I feel Ivermectin for prevention is very effective, Ivermectin for treatment of mild to moderate conditions is also very effective, and the addition of intravenous Vitamin C for moderate to severe conditions are truly working. Early on I was only getting veterinary Ivermectin. But in a short while I got hold of a supply of 15mg Ivermectin capsules, and I have relatively unlimited supply of this which I can share to those who need it. Most, importantly, I would like to share my knowledge and experience in managing COVID-19 patients. I have been joking my peers in calling the virus a chicken virus although it is a bat virus. I say it is chicken because I think it should just be an easy virus to handle.
Prophylaxis
(Prevention)
(Prevention)
Treatment
Six Mechanisms of Action How IVERMECTIN Knocks Down COVID-19:
1) IVERMECTIN prevents viral entry into host cells.
Viruses in general do not have its own machinery to replicate. It makes use of the host cells’ ribosomal complex in order to transcribe and translate its genomic material. And this can only be achieved if the virus gains entry into the host cells. SARS CoV-2 has its spike protein that happened to have an exact configuration with that of the ACE-2 protein on the cell membranes of the targets cells (alveolar lining of the lungs, endothelium of the blood vessels, lining of the gut, the heart, the brain, and certain other organs). It works in a manner of a lock- and-key arrangement, that of the ACE-2 protein and the spike protein. IVERMECTIN specifically binds onto the spike protein (S-protein) and practically dismember the virus thereby disabling it to gain entry into its target cells.
2) IVERMECTIN prevents viral entry into the nucleus of the cells.
The virus attaches on a heterodimer protein Importin α / Importin β-1 which serves as a transport system in order for it to gain entry into the nucleus. Then the virus shuts down the nucleus thereby immune responses against it is practically suppressed. IVERMECTIN inhibits this heterodimer protein and the virus is prevented from latching onto it and is thus prevented from being transported into the nucleus, thereby disabling the virus from performing this critical function.
3) IVERMECTIN inhibits genomic transcription and translation.
Helicase enzyme is necessary in order to initiate genomic transcription and eventually complete its replication through protein translation. IVERMECTIN was found to cause profound inhibition of this very crucial enzyme.
4) IVERMECTIN prevents cytokine storm.
SARS CoV-2 has 2 pathophysiologic pathways. The more common of this is that which leads to Acute Respiratory Distress syndrome. This results from the cytokine storm that was created as a result of overwhelming viral proliferation. IVERMECTIN was found to be a very potent immune system modulator as it practically suppresses cytokine storm that causes leakage of fluids into the alveolar spaces consequently leading to ARDS.
5) IVERMECTIN prevents CD-147 vascular occlusion.
The second pathophysiologic pathway seen in COVID-19 is vascular occlusion caused by hyper-coagulation of blood mediated by the protein receptor present in the cell membrane of red blood cells called CD-147. This leads to a condition much similar to a disseminated intravascular coagulation and was observed to be occur-ring among COVID-19 patients. IVERMECTIN was found to inhibit the stimulation of this receptor by the virus and thereby preventing the hypercoagulability state.
6) IVERMECTIN increases interferon production and enhances its effects.
One very important mechanism of immune response against viruses is the production of interferon. Interferon are like the bullets fired directly against the viruses by the immune cells. IVERMECTIN was found to specifically stimulate interferon production and enhancement.
Six Mechanisms of Action How IVERMECTIN Knocks Down COVID-19:
1) IVERMECTIN prevents viral entry into host cells.
Viruses in general do not have its own machinery to replicate. It makes use of the host cells’ ribosomal complex in order to transcribe and translate its genomic material. And this can only be achieved if the virus gains entry into the host cells. SARS CoV-2 has its spike protein that happened to have an exact configuration with that of the ACE-2 protein on the cell membranes of the targets cells (alveolar lining of the lungs, endothelium of the blood vessels, lining of the gut, the heart, the brain, and certain other organs). It works in a manner of a lock- and-key arrangement, that of the ACE-2 protein and the spike protein. IVERMECTIN specifically binds onto the spike protein (S-protein) and practically dismember the virus thereby disabling it to gain entry into its target cells.
2) IVERMECTIN prevents viral entry into the nucleus of the cells.
The virus attaches on a heterodimer protein Importin α / Importin β-1 which serves as a transport system in order for it to gain entry into the nucleus. Then the virus shuts down the nucleus thereby immune responses against it is practically suppressed. IVERMECTIN inhibits this heterodimer protein and the virus is prevented from latching onto it and is thus prevented from being transported into the nucleus, thereby disabling the virus from performing this critical function.
3) IVERMECTIN inhibits genomic transcription and translation.
Helicase enzyme is necessary in order to initiate genomic transcription and eventually complete its replication through protein translation. IVERMECTIN was found to cause profound inhibition of this very crucial enzyme.
4) IVERMECTIN prevents cytokine storm.
SARS CoV-2 has 2 pathophysiologic pathways. The more common of this is that which leads to Acute Respiratory Distress syndrome. This results from the cytokine storm that was created as a result of overwhelming viral proliferation. IVERMECTIN was found to be a very potent immune system modulator as it practically suppresses cytokine storm that causes leakage of fluids into the alveolar spaces consequently leading to ARDS.
5) IVERMECTIN prevents CD-147 vascular occlusion.
The second pathophysiologic pathway seen in COVID-19 is vascular occlusion caused by hyper-coagulation of blood mediated by the protein receptor present in the cell membrane of red blood cells called CD-147. This leads to a condition much similar to a disseminated intravascular coagulation and was observed to be occur-ring among COVID-19 patients. IVERMECTIN was found to inhibit the stimulation of this receptor by the virus and thereby preventing the hypercoagulability state.
6) IVERMECTIN increases interferon production and enhances its effects.
One very important mechanism of immune response against viruses is the production of interferon. Interferon are like the bullets fired directly against the viruses by the immune cells. IVERMECTIN was found to specifically stimulate interferon production and enhancement.
Dr. Allan A. Landrito contact info:
dr.allan.landrito@gmail.com
or cellphone: 09323137060
dr.allan.landrito@gmail.com
or cellphone: 09323137060
HUNGARY:
Please watch the video below...
ETHIOPIA:
According to ncbi.nlm.nih, 81% of the 115,000,000 people in Ethiopia take Ivermectin several times per year to prevent river blindness caused by a parasite that is prevalent in their country. Since the onset of the pandemic there have been approximately 620 deaths attributed to COVID-19. That is a death rate of approximately 5 per million.
DENMARK:
| praeparatanmeldelse_scatol_20200501.pdf |
MISCELLANEOUS:
DONALD TRUMP:
According to his White House health records, United States President Donald Trump has used Ivermectin in cream form to treat the skin condition rosacea. It is believed that he is no longer using it, but that he had done so in the past.
https://rosacea-support.org/trump-uses-soolantra-for-his-rosacea.html
https://rosacea-support.org/trump-uses-soolantra-for-his-rosacea.html
TOP WEBSITES AND BLOGS:
PDFs:
Ivermectin for COVID-19
| free_report_clinical_landscape_study_on_ivermectin_for_covid19.pdf |
| robert_armstrong_-front-line_prevention_and_treatments_for_covid-19.pdf |
